Top insider buys: Sep 12 – Sep 18, 2022

The largest open-market purchases company insiders reported on SEC Form 4 between Sep 12 – Sep 18, 2022.

Week 37, 2022

#	Company	Who bought	Shares	Value	Source
1	EWTX Edgewise Therapeutics, Inc.	2 officers/directors Cluster buy Peter A. Thompson, ORBIMED ADVISORS LLC, Novo Holdings A/S	968,992	$10.0M +$5.0M by large holders	SEC filings
2	SBUX STARBUCKS CORP	2 officers/directors Cluster buy Mellody L. Hobson, Richard E. Allison Jr.	64,750	$6.0M	SEC filings
3	AIKI AIkido Pharma Inc.	3 officers/directors Cluster buy Soo Yu, Anthony Hayes, Kyle Michael Wool	197,399	$1.2M	SEC filings
4	CRK COMSTOCK RESOURCES INC	2 officers/directors Cluster buy Morris E. Foster, M. Jay Allison	64,000	$1.2M	SEC filings
5	MEDP Medpace Holdings, Inc.	2 separate filers August J. Troendle, Medpace Investors, LLC	726,354	$115.2M	SEC filings
6	PLPC PREFORMED LINE PRODUCTS CO	3 separate filers Robert G. Ruhlman, Katherine E. Wensink, Randall M. Ruhlman	2,431,200	$107.9M	SEC filings
7	ET Energy Transfer LP	Executive Chairman Kelcy L. Warren	3,000,000	$36.0M	SEC filings
8	FRSH Freshworks Inc.	2 separate filers Sameer K. Gandhi, Accel Leaders 3 GP Associates L.L.C.	2,080,058	$30.5M	SEC filings
9	VVX V2X, Inc.	2 separate filers Dino M. Cusumano, American Industrial Partners Capital Fund VI, L.P.	750,840	$30.0M	SEC filings
10	SRPT Sarepta Therapeutics, Inc.	Director Michael Andrew Chambers	57,100	$6.0M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.